Back to search
FDAFDA · Food and drugs·Recall number D-1115-2017

Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811, Distributed by: Truxton, Inc. Bellmawr, NJ 08031, NDC: 0463-6352-10

Published August 30, 2017 · Recall initiated: April 20, 2017

Summary

FDA records drug Class II recall D-1115-2017, published August 30, 2017 and initiated April 20, 2017. Recalling firm: C. O. Truxton; Status: Terminated; Reported quantity: unknown; Lot: Lot # C0260416A; Exp. 03/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mixup; potentially mislabeled

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
C. O. Truxton
Distributor
Nationwide
Lot
Lot # C0260416A; Exp. 03/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811, Distributed by: Truxton, Inc. Bellmawr, NJ 08031, NDC: 0463-6352-10 recalled?

Yes. FDA published recall D-1115-2017 on August 30, 2017. Reported hazard: Labeling: Label Mixup; potentially mislabeled

What should I do if I have this product?

Voluntary: Firm initiated · Press Release